Menu
Currency
GWAS Study

Multi-ancestry meta-analysis identifies genetic modifiers of age-at-onset of Alzheimer's disease at known and novel loci.

Blue EE, Broome J, Xue D et al.

40883957 PubMed ID
GWAS Study Type
41527 Participants
69 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

BE
Blue EE
BJ
Broome J
XD
Xue D
KH
Kingston H
CN
Chapman NH
GS
Gogarten S
NA
Naj AC
WE
Wijsman EM
Chapter II

Abstract

Summary of the research findings

Introduction: Much of Alzheimer's disease (AD) risk is explained by age, apolipoprotein E (APOE) genotype, and sex. We sought to identify genetic modifiers of age at onset (AAO) of AD while probing the influence of sex and APOE among those with diverse ancestry.

27,993 European ancestry individuals, 6,949 Black individuals, 6,530 Hispanic individuals, 55 individuals

Chapter III

Study Statistics

Key metrics and study information

41527
Total Participants
GWAS
Study Type
No
Replicated
European, African unspecified, Hispanic or Latin American
Ancestry
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.